Phase I/II study of triweekly administration regimen of irinotecan and TS-1 in patients with advanced colorectal cancer.
Phase of Trial: Phase I/II
Latest Information Update: 08 Aug 2012
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 10 Sep 2008 New trial record.